
IQVIA Hlds (IQV) Stock Forecast & Price Target
IQVIA Hlds (IQV) Analyst Ratings
Bulls say
IQVIA Holdings has demonstrated a robust outlook based on key financial indicators, with a reported 5% increase in request-for-proposals (RFP) flow across all market segments, notably in the Evidence-Based Practice (EBP) sector, which is expected to yield increased deal volumes in the future. The company's significant investment plan of $2 billion for M&A and share buybacks in 2025 aligns with anticipated growth, underscored by a 5.5% growth in net new business backlog at constant foreign exchange rates, supporting a forecasted revenue growth of 4-7% for its research and development solutions segment. Additionally, the resurgence of the Technology and Analytics Solutions (TAS) segment highlights a combination of pent-up demand and strong organic growth, further positioning IQVIA for positive financial performance moving forward.
Bears say
IQVIA Holdings Inc. faces significant challenges due to a prolonged COVID-related market disruption and increased interest expenses, which have adversely affected investor sentiment and earnings per share (EPS) growth since the first quarter of 2022. The company's backlog remains flat, exacerbated by foreign exchange headwinds and a subsequent downward revision of reported backlog by $500 million, indicating potential issues with demand generation. Additionally, a competitive pricing landscape combined with a 60 basis points decline in gross margins, alongside pressures from delayed trials and rising interest rates, suggests a bleak financial outlook moving forward.
This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.
IQVIA Hlds (IQV) Analyst Forecast & Price Prediction
Start investing in IQVIA Hlds (IQV)
Order type
Buy in
Order amount
Est. shares
0 shares